Journal of Food Bioactives, ISSN 2637-8752 print, 2637-8779 online |
Journal website www.isnff-jfb.com |
Opinion
Volume 6, June 2019, pages 1-5
Guarana as a source of bioactive compounds
Table
Health effects | In vitro/in vivo | Dose | References |
---|---|---|---|
Effects on metabolic comorbidities (obesity, hypertension, type 2 diabetes, and metabolic syndrome) | In vivo: elderly humans | Twice or more times a week | Krewer et al. (2011) |
Oxidative stress and metabolic disorders (effects on the oxidation of LDL-c) | In vivo: blood samples of elderly humans; In vitro: isolated LDL-c | In vivo: at least 5 times per week In vitro: 0.05, 0.1,0.5,1, and 5 µg·mL−1; | Portella et al. (2013) |
Oxidative stress | In vivo: overweight humans; Ex vivo: oxidation of LDL-c and total plasma antioxidant capacity | In vivo: 3 g of the powder diluted in 300 ml of water before intake, daily for 15 days before breakfast | Yonekura et al. (2016) |
Antihyperglycemic | In vitro: inhibition of activity of carbohydrate-hydrolyzing enzymes (α-amilase and α-glucosidase) | Guarana extracts after in vitro digestion α-amilase: 0.315, 0.525 and 0.875 mg·mL−1); α-glucosidase: 0.4 and 0.8 mg·mL−1 | Silva et al. (2018) |
Gut microbial composition and redox and inflammatory parameters | In vivo: Wistar rats | Guarana seed powder the major compounds are caffeine (34.19 ± 1.26 mg·g−1), theobromine (0.14 ± 0.01 mg·g−1), (+)- catechin (3.76 ± 0.12 mg·g−1), and (−)-epicatechin (4.05 ± 0.16 mg·g−1) | Silveira et al. (2018) |
Antimicrobial activity | In vitro: antibacterial potential of the guarana extracts against Streptococcus mutans | The aqueous extract (AqE) from the 5% (w/v) guarana seeds; crude (EBPC) extracts and semi-purified (EPA and EPB) fractions | Yamaguti-Sasaki et al. (2007) |
Cognitive performance and mental fatigue | In vivo: healthy young adults | vitamin/mineral/guarana combination | Kennedy et al. (2008) |
Mood, cognitive performance and functional brain activation | In vivo: healthy young adults | vitamin/mineral/guarana combination | Scholey et al. (2013) |
Antiproliferative effect | In vitro: breast cancer cells MCF-7 | Guarana extracts 1, 5 and 10 µg·mL−1 | Hertz et al. ( 2015) |
Anticancer effect | In vivo: female C57Bl/6 mice | 2.0 mg·g−1 body weight | Fukumasu et al. (2008) |
Antitumor effect | In vitro: Colorectal and breast cancer cell lineages HT-29 and MCF-7 cells | 0.1, 1, 10, and 100 µg·mL−1 | Cadoná et al. (2017) |